LEXOMIIL WITHDRAWAL SYMPTOMS MAY INCLUDE:

abdominal pains, aching, agoraphobia, anxiety, blurred vision, body vibrations, changes in perception, diarrhea, distended abdomen, feeling of unreality, flu-like symptoms, flatulence, food cravings, hair loss, heart palpitations, heavy limbs, increased allergies, increased sense of smell, insomnia, lethargy, loss of balance, metallic taste, muscle spasms, nightmares, panic attacks, paranoia, persistent & unpleasant memories, severe headaches, shaking, short term memory loss, sore mouth and tongue, sound & light sensitivity, speech difficulties, sweating, suicidal thoughts, tinnitus, unusually sensitive, fear

LEXOMIL SIDE EFFECTS MAY INCLUDE: 

dizziness, sedation (excessive calm), unsteadiness, weakness, agitation, change in appetite, depression, eye function disorders, headache, memory impairment, mental disorientation, nausea, skin problems, sleep disturbance, stomach, intestinal disorders, tolerance and dependency. abdominal pains, aching, agoraphobia, anxiety, blurred vision, body vibrations, changes in perception, diarrhea, distended abdomen, feeling of unreality, flu-like symptoms, flatulence, food cravings, hair loss, heart palpitations, heavy limbs, increased allergies, increased sense of smell, insomnia, lethargy, loss of balance, metallic taste, muscle spasms, nightmares, panic attacks, paranoia, persistent & unpleasant memories, severe headaches, shaking, short term memory loss, sore mouth and tongue, sound & light sensitivity, speech difficulties, sweating, suicidal thoughts, tinnitus, unusually sensitive, fear

LEXOMIL ADVERSE REACTIONS MAY INCLUDE: 

Psychiatric Disorders: Confusional state, emotional disturbances, libido disorders, nervousness and depression have been reported. 

Paradoxical reactions such as restlessness, agitation, irritability, aggression, delusion, anger, nightmares, sleep disorders, hallucinations, psychosis, inappropriate behaviour and other adverse behavioural effects are known to occur with benzodiazepines or benzodiazepine-like agents. Should this occur, the use of LEXOTAN should be discontinued. Such reactions are more likely to occur in children and elderly patients than in other patients. 

Dependence: Chronic use (even at therapeutic doses) may lead to the development of physical and psychic drug dependence: discontinuation of therapy may result in withdrawal or rebound phenomena (see PRECAUTIONS; Dependence).Abuse of benzodiazepines has been reported.

Nervous System Disorders: Drowsiness and ataxia become less common with repeated administration. Headache, dizziness, decreased alertness, seizures, tremor, speech disorders and incontinence have been reported. 

Anterograde amnesia may occur using therapeutic dosages with the risk increasing at higherdosages. Amnestic effects may be associated with inappropriate behaviour.

Eye Disorders: Diplopia and blurred vision have been reported. 

Gastrointestinal Disorders: Gastrointestinal disorders, dry mouth, nausea and vomiting have been reported. 

Metabolic and Nutritional Disorders: Anorexia has been reported. 

Skin and Subcutaneous Tissue Disorders: Skin reactions including pruritis and rash have been reported.

Musculoskeletal and Connective Tissue Disorders: Muscle weakness and muscle spasm have been reported. 

General Disorders and Administration Site Conditions: Fatigue. 

Injury, Poisoning and Procedural Complications: An increased risk for falls and fractures has been reported in elderly benzodiazepine users. 

Respiratory Disorders: Respiratory depression has been reported. 

Cardiac Disorders: Cardiac failure including cardiac arrest, hypotension, tachycardia and palpitations have been reported. 

Investigations: Instances of decreased haemoglobin and increased white cell counts have been reported.